Grants and Contracts Details
Description
Chlamydia trachomatis represents a significant health concern world-wide. A
substantial burden exists due to the prevalence and the combined health and
socioeconomic impact of acute and chronic disease. All Chlamydia species express a
type III secretion system (T3SS), and this mechanism likely contributes significantly to
overall pathogenesis. Chlamydiae are obligate intracellular parasites that undergo a
complex developmental cycle, and this biology has historically impeded rapid progress
in understanding pathogenesis. The newly acquired ability to inactivate chlamydial
genes via insertion or deletion mutagenesis has greatly facilitated characterization of
virulence factors. Unfortunately, significant barriers remain in the application of genetics
in elucidating molecular mechanisms of virulence. For example, there is currently no
mechanism to generate null strains for gene products that are absolutely essential for
chlamydial propagation in cell culture. To this end, we have adapted the fluorescencereported
allelic exchange mutagenesis technique to facilitate creation of conditional null
strains in essential genes. Preliminary data describing such a situation for a type III
effector gene are presented herein. We propose to validate and further develop our
approach while revealing the function of a highly important effector protein. At the end
of these studies, we will have established new approaches that will benefit the entire
Chlamydia research community and advance the understanding of how T3S manifests
during chlamydial infection.
Status | Finished |
---|---|
Effective start/end date | 2/11/19 → 5/31/21 |
Funding
- National Institute of Allergy and Infectious Diseases: $406,016.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.